HtrA2/Omi, a Sheep in Wolf's Clothing  by Vaux, David L & Silke, John
Previews
251
mRNA requirements for gag-pol readthrough, less is new cells. Whereas virions derived from the RT-minus
known about the regulatory mechanisms that control and eRF1 interaction-deficient mutants failed to pro-
this process. duce any progeny virus even after two weeks, viral parti-
In this issue of Cell, Orlova et al. (2003) identify eukary- cles derived from the wild-type vector were highly infec-
otic release factor 1 (eRF1) as a cellular protein that tious. Thus, the effect of RT on gag-pol readthrough is
interacts with MoMLV reverse transcriptase (RT), a viral dependent on an interaction between RT and eRF1.
enzyme encoded by pol. eRF1 has an integral role in By demonstrating that an MoMLV-RT upregulates its
the normal termination of translation (Kisselev et al., own expression through a specific interaction with the
2003). When the moving ribosome encounters a stop host translation termination machinery, Orlova et al.
codon, eRF1 binds in the A-site and, with the ribosomal have discovered a new way in which retroviruses manip-
RNA, facilitates the cleavage of the peptidyl-tRNA bond ulate cellular processes to their advantage. This exciting
by an unknown mechanism to release the newly synthe- discovery raises many questions about the mechanism
sized protein. Given the role of eRF1 in translation termi- by which the RT-eRF1 interaction affects stop codon
nation, Orlova et al. set out to further investigate the suppression; like all interactions in such feedback loops,
potential interaction between eRF1 and RT and whether the key answers lie in the binding equilibriums. What is
or not RT is involved in the regulation of its own ex- the effect of RT on the affinity of eRF1 for mRNA, the
pression. ribosome, and the other translation release factor,
The authors first present evidence supporting an inter- eRF3? What is the affinity of RT for eRF1, and do other
action between RT and eRF1 both in vitro and in vivo. cellular and viral cofactors play a role in this regulatory
In vitro, RT is retrieved from solution by an eRF1-gluta- circuit? A biophysical examination of this system could
thione S transferase (GST) fusion bound to glutathione explain even further how MoMLV masters the delicate
beads. Both domains of RT, the DNA polymerase do- regulation of Gag and Gag-Pol expression.
main and the RNase H domain, appear to interact with
eRF1 by this assay, although the interaction with the
DNA polymerase domain appears to be weaker than the Christina Bradley and Robert Craigie
interaction with full-length RT. In vivo, overexpression Laboratory of Molecular Biology
of eRF1 leads to its incorporation into viral particles, National Institute of Diabetes and Digestive and Kidney
suggesting that the translation release factor is being Diseases
recruited by viral proteins. When portions of the RT gene, National Institutes of Health
or the entire RT gene, are deleted, eRF1 is not incorpo- Bethesda, Maryland 20892
rated into the viral particles, suggesting that eRF1 inter-
acts specifically with RT. Selected Reading
After confirming the putative interaction between RT
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Rev. 64, 239–280.Gag-Pol readthrough with exciting results. Using a re-
Kisselev, L., Ehrenberg, M., and Frolova, L. (2003). EMBO J. 22,porter construct consisting of the gag-pol junction
175–182.flanked by two different luciferase genes, they observed
Orlova, M., Yueh, A., Leung, J., and Goff, S.P. (2003). Cell 115, thisthat an increase in RT expression in vivo leads to an
issue, 319–331.increase in expression of the luciferase fusion protein.
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Swanstrom, R., and Wills, J.R. (1997). Synthesis, assembly and pro-eRF1, further supporting the interaction between these
cessing of viral proteins. In Retroviruses, J.M. Coffins, S.H. Hughes,proteins. To investigate the role of RT on the expression
and H.E. Varmus, eds. (Cold Spring Harbor, NY: Cold Spring Harborof Gag-Pol in MoMLV infected cells, the authors trans-
Laboratory Press), pp. 263–334.fected cells with proviral DNA lacking the RT gene. In
the absence of RT, the expression level of Gag-Pol is
not detectable by Western blot analysis, whereas the
expression of Gag is equal to that observed in cells
transfected with the wild-type provirus. These combined
HtrA2/Omi, a Sheep inobservations, that increasing RT can increase read-
through at the gag-pol junction and that the removal of Wolf’s Clothing
RT prevents readthrough, strongly support a role for RT
in the regulation of its own synthesis.
Is the regulatory role of RT related to its interaction
with eRF1? To answer this question, Orlova et al. iso-
Mammalian mitochondrial HtrA2/Omi was originallylated mutants of RT that fail to interact with eRF1. Similar
described as an apoptosis inducer, but rather thanto the effect of removing the RT gene entirely, cells
having extra cells, mice with mutant HtrA2/Omi suffertransfected with proviral DNA containing these RT muta-
from a neurodegenerative disease due to progressivetions failed to express the Gag-Pol protein. The Gag
mitochondrial damage. This suggests that instead ofprotein was expressed at wild-type levels in these cells
promoting cell death by antagonizing inhibitor of apo-but remained unprocessed, consistent with the fact that
ptosis (IAP) proteins, the primary function of HtrA2/protease is encoded by pol. The viral particles produced
Omi is to handle misfolded proteins in the mito-from these mutant proviral vectors, and from the RT-
minus proviral vector, were harvested and used to infect chondria.
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HtrA2/Omi is a mammalian serine protease that resides example of a protein that was once thought solely to
in the mitochondria of healthy cells, but during apoptosis be a mediator of apoptosis, but is actually essential for
is released into the cytosol, where it can bind to IAPs. mitochondrial function. Nevertheless, it remains possi-
The processed amino terminus of HtrA2/Omi carries an ble that HtrA2/Omi, and the other mitochondrial IAP
IAP binding motif (IBM) similar to those at the N termini binding proteins, have a secondary function that in-
of Reaper, Grim, HID, Sickle, and Jafrac2, the IAP antag- volves their ability to bind to IAPs once they are released
onists from Drosophila. These observations led to the into the cytoplasm.
notion that HtrA2/Omi promotes apoptosis by antago- Four mammalian mitochondrial proteins were identi-
nizing IAPs upon release from the mitochondria. Consis- fied in detergent-treated cell lysates that bound to XIAP,
tent with this idea, HtrA2/Omi can relieve the inhibition and three of them had obvious mitochondrial duties, the
of caspases imposed by XIAP in vitro. However, HtrA2/ exception being smac/DIABLO (Verhagen et al., 2000).
Omi closely resembles E. coli HtrA/DegP, a protein that Furthermore, a cursory scan through the databases re-
does not promote cell death, but does the opposite—it veals many more mitochondrial proteins that have po-
protects bacteria when they are grown at high tempera- tential IAP binding motifs at their real or processed N
ture by refolding or degrading misfolded proteins termini. The surprise is not that a mitochondrial protein,
(Spiess et al., 1999). Has the closest homolog of a cell such as HtrA2/Omi, has an important role within the
survival protein in bacteria switched function to be a mitochondria, but that there are so many mitochondrial
proapoptotic mitochondrial protein in mammals? Is proteins with the potential to act as IAP antagonists.
HtrA2/Omi a promoter of cell death, or does it have One possible explanation for this large number of mi-
other functions? tochondrial IAP binding proteins rests on the ability of
If the predominant function of HtrA2/Omi were to re- IAPs to act as E3 ligases that multiubiquitinate and pro-
fold and degrade misfolded proteins in the mitochon- mote the destruction of proteins with an IAP binding
dria, just as HtrA does in bacteria, then loss of the gene motif (IBM). According to the N-end rule (Varshavsky,
would be predicated to result in progressive mitochon- 2003), amino-terminal Ala is a destabilizing residue. Be-
drial dysfunction, manifesting as neurological disease cause the IBM is very small and has an N-terminal ala-
(Vaux and Silke, 2003). If, on the other hand, HtrA2/Omi’s nine, it might exist on mitochondrial proteins so that
main function were to promote apoptosis, then loss of they can be ubiquitinated and degraded by IAPs if they
the gene would result in abnormal cell survival. are inadvertently released into the cytosol. In addition,
A paper from Emad Alnemri’s group identifying a if a cell’s mitochondria were sufficiently damaged, the
mouse with an inactivating point mutation highlights released IAP binding proteins would oblige it to undergo
the importance of the mitochondrial role of HtrA2/Omi apoptosis. Thus, mammalian mitochondrial proteins
(Jones et al., 2003). The mnd2 (motor neuron degenera- might have IAP binding motifs (IBMs) in order to facilitate
tion 2) mutant mice suffer a neurodegenerative disease their own destruction, with the ability to promote apo-
that results in muscle wasting and death by six weeks ptosis being a bonus. This might also explain the appar-
of age. The mutation resides in a noncatalytic serine ent comparative potency of the specialist insect IAP
residue that does not affect the processing or localiza- antagonists, Reaper, Grim, and HID, whose true mam-
tion of the mutant HtrA2/Omi protein, but renders it pro- malian homologs might yet be found.
teolytically inactive. Therefore, the proteolytic activity of As there are several potential mammalian mitochon-
HtrA2/Omi is required to maintain healthy mitochondria. drial IAP antagonists, loss of the IBM motif of one protein
Strikingly, rather than being resistant to cell death, cells is unlikely to affect the IAP antagonizing ability of the
from these mice were more sensitive to apoptosis in- mitochondria as a whole. Therefore, although mitochon-
duced by tunicamycin, etoposide, antimycin A, and hy- drial proteins may promote apoptosis, perhaps it is not
drogen peroxide, consistent with HtrA2/Omi’s role in the wolf’s clothing (i.e., the IBM) that is important, but
protecting mitochondria, but contrary to what would be
rather that the sheep hunt in packs.
expected if it were simply a proapoptotic protein.
Although these mice have demonstrated an essential
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